Mike Petchel

About Mike Petchel

Experienced finance professional focused on unlocking value through analysis, rigor, acumen and collaboration. Strong team leadership guided by core business expertise, strategic outlook and servant tenets. Created multiple feasibility proposals that have led to revenue gains (1-20M+) in areas of: asset in-licensing, organic life cycle management, pricing dynamics, new product introductions, and site optimization. Experience in big pharma and pre-commercial startup predominantly in Oncology (systemic therapy, supportive care), but also in antibiotics, anesthetics and antigens. Highlighted focus on Branded novel therapies (Immuno-oncology and Targeted Therapy), Biologics, and Generics (Injectables and Orals). Expert in pharmaceutical Gross to Net accounting and forecasting, government pricing & commercial contracting, and the commercial data ecosystem. Synthesized primary and secondary research, market landscape, and competitive intelligence to derive driver-based sales and demand forecasts used by internal stakeholders, C-suite, Board of Directors, and the Investment community. Have advanced FP & A divisions up the value curve from reactive to prescriptive. Integrated systems ranging from local general ledgers to enterprise-wide solutions. While reporting directly to the CFO, designed and operationalized a financial operating model that included 3 statement modeling, 13-week Cash Flow forecasting, and 18-24 months rolling forecast to support agile decision making. Driven by enthusiasm to deliver results to customers, the company, and investors.

Experience

1. Director Commercial Finance, Data Analytics, Fp & a

   Thermo Fisher Scientific

   Jul 2025 — Present · Pittsburgh, PA, US

Education

• Schreyer Honors College at Penn State

  Bachelor's Degree

• Argosy University-Phoenix Online Division

  Master of Business Administration (M.B.A.)